Livrare gratuită pentru comenzile peste 349,00 lei.

Verifică starea comenzii

Faceți parte dintr-o comunitate de iubitori de cărți din întreaga lume și beneficiați de o mulțime de avantaje Creați-vă un cont gratuit

Transport gratuit la punctele de livrare Pick Up peste 349.00 lei

Packeta 15.00 lei Serviciul de curierat Cargus 28.00 lei Easybox 20.00 lei Punct FAN 16.00 lei Punct DPD 17.00 lei Curier DPD 25.00 lei FAN Courier 25.00 lei

Contact

Cum să cumpăr

Ajutor

Contul meu

▸ Gol :-(

Livrare gratuită pentru comenzile peste 349,00 lei.

Biologic and Systemic Agents in Dermatology

Paul Yamauchi

Limba

engleză

Carte Copertă tare

Codul Libristo: 16830518

Editura Springer International Publishing AG, ianuarie 2018

Written by leading experts in the field and designed for dermatologists and residents, this book inc... Descrierea completă

Codul Libristo: 16830518

462 b

1 006.04 lei

În depozitul extern Expediem în 10-13 zile

Până la 30 de zile pentru returnare

Clienții au cumpărat de asemenea

Burgen und Schloesser der Harzregion 4 Bernd Sternal

Carte broșată

75.72 lei

Granice zrównowazonego partnerstwa. Czesc V Boris Zalesski

Carte broșată

198.78 lei

Gaster Gorm Gallionn

Carte broșată

90.87 lei

Le Sujet thique Domingos Vieira

Carte broșată

252.36 lei

Castingprozesse im deutschen Film- und Fernsehbereich Jana Wichmann

Carte broșată

262.81 lei

Written by leading experts in the field and designed for dermatologists and residents, this book includes evidence-based medicine that underscores the clinical data, as well as practical tips on how to use both biologic and systemic agents in the field of dermatology. In the past decade, there have been several groundbreaking advances in medical dermatology. Novel biologic and systemic agents have been developed to treat inflammatory disorders, including psoriasis and atopic dermatitis, as well as skin malignancies such as melanoma. Biologic and Systemic Agents in Dermatology encompasses these developments by describing the mechanism of action of these various agents and the clinical efficacy and safety to treating these respective disorders. The utilization of biologic and systemic agents in other dermatologic conditions, pharmacoeconomics, pharmacovigilance, and clinical trials outcomes are discussed as well as topics including tumor necrosis, conventional systemic agents for psoriatic disease, and oral agents for atopic dermatitis.